XML 17 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summarizes Stock Option Activity Under Equity Intensive Plan

The following table summarizes stock option activity under the equity incentive plans for the nine months ended September 30, 2015:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted-

Average

Remaining

Contractual Life

(in years)

 

Outstanding at December 31, 2014

 

 

5,137,914

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

5,713,899

 

 

$

7.92

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(7,715

)

 

$

0.42

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(1,032,742

)

 

$

0.82

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2015

 

 

9,811,356

 

 

$

4.97

 

 

$

83,335

 

 

 

7.65

 

Vested and Exercisable at September 30, 2015

 

 

4,046,009

 

 

$

5.32

 

 

$

34,694

 

 

 

8.18

 

 

Summary of Options Outstanding and Vested

The following table provides a summary of options outstanding and vested as of September 30, 2015:

 

Exercise Prices

 

 

Number

Outstanding

 

 

Weighted-

Average

Life (in

Years)

 

 

Number

Exercisable

 

 

Weighted-

Average

Life (in

Years)

 

$0.22

 

 

 

1,404,060

 

 

 

8.46

 

 

 

987,472

 

 

 

8.46

 

$0.42

 

 

 

1,115,144

 

 

 

8.84

 

 

 

949,281

 

 

 

8.78

 

$1.76

 

 

 

1,578,253

 

 

 

9.20

 

 

 

357,420

 

 

 

9.20

 

$2.00

 

 

 

2,406,949

 

 

 

9.37

 

 

 

792,673

 

 

 

9.37

 

$2.20

 

 

 

1,851,500

 

 

 

3.48

 

 

 

231,438

 

 

 

3.48

 

$

25.00

 

 

 

1,455,450

 

 

 

6.73

 

 

 

727,725

 

 

 

6.73

 

 

 

 

 

 

9,811,356

 

 

 

7.65

 

 

 

4,046,009

 

 

 

8.18

 

 

Weighted Average Assumptions of Fair Value of Stock Options Under Black-Scholes Option Pricing Model

The Company uses a Black-Scholes option-pricing model to determine the fair value of stock-based compensation under ASC Topic 718, Stock Compensation. The assumptions used for employee and non-employee stock options are presented in the table below:

 

 

 

 

Nine Months Ended September 30,

 

 

 

2015

 

 

2014

 

 

 

Employee

Grants

 

 

Non-Employee

Grants

 

 

Employee

Grants

 

 

Non-Employee

Grants

 

Expected term (years)

 

4.00-5.52

 

 

 

10.00

 

 

5.00-5.52

 

 

 

10.00

 

Risk-free interest rate

 

1.45%-1.79%

 

 

 

2.14%

 

 

1.58%-1.89%

 

 

 

2.70%

 

Expected volatility

 

 

80%

 

 

 

80%

 

 

 

91%

 

 

 

91%

 

Dividend yield

 

 

0%

 

 

 

0%

 

 

 

0%

 

 

 

0%

 

Weighted-average grant date fair value

 

$12.08

 

 

$5.19

 

 

$0.16

 

 

$0.19

 

 

Restricted Stock Units Activity

The following table summarizes the restricted stock units activity under the 2015 Plan:

 

 

 

Number of Restricted

Stock Units

Outstanding

 

 

Weighted-Average

Grant Date

Fair Value

 

Unvested balance at December 31, 2014

 

 

-

 

 

 

 

 

Granted

 

 

970,300

 

 

$

25.00

 

Vested, net of shares withheld for employee payroll taxes

 

 

(388,538

)

 

$

25.00

 

Shares withheld for employee payroll taxes

 

 

(96,612

)

 

$

25.00

 

Unvested balance at September 30, 2015

 

 

485,150

 

 

$

25.00

 

 

Stock Based Compensation Expenses Included in Operations Statement

The following table presents all stock-based compensation as included in the Company’s condensed consolidated statements of operations:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

Stock-based compensation expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants for Class A common stock to an officer and a

   director related to Inex Bio, Inc. acquisition (Note 3)

 

$

 

 

$

 

 

$

22,747

 

 

$

 

Warrants for Class A common stock to an officer

 

 

4,745

 

 

 

 

 

 

80,663

 

 

 

 

 

Employee stock options

 

 

16,424

 

 

 

26

 

 

 

20,033

 

 

 

190

 

Non-employee stock options

 

 

784

 

 

 

3

 

 

 

3,074

 

 

 

6

 

Restricted stock units

 

 

14,150

 

 

 

 

 

 

14,150

 

 

 

 

 

 

$

36,103

 

 

$

29

 

 

$

140,667

 

 

$

196

 

Stock-based compensation expense in operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

364

 

 

$

 

 

$

1,140

 

 

$

 

Selling, general and administrative

 

 

35,739

 

 

 

29

 

 

 

139,527

 

 

 

196

 

 

 

$

36,103

 

 

$

29

 

 

$

140,667

 

 

$

196